BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
88 hedge funds and large institutions have $176M invested in BioSpecifics Technologies Corp. in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 34 reducing their positions, and 10 closing their positions.
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1% more funds holding
Funds holding: 87 → 88 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 34
6% less capital invested
Capital invested by funds: $187M → $176M (-$11.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7.85M |
| 2 |
Renaissance Technologies
New York
|
+$1.43M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$837K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$671K |
| 5 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$472K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$2.47M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$2.32M |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.38M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$813K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$794K |
BSTC Hedge Fund Activity: Q4 2017 in Review
88 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2017, worth a combined $176M — down 6% from $187M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new BSTC positions and 10 closed out — a net gain of 1 holder — while 33 added to existing stakes and 34 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $7.85M. The largest seller was Northpointe Capital, cutting an estimated $2.47M.
- 88 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2017, up from 87 in Q3 2017.
- Funds reported $176M of BioSpecifics Technologies Corp. stock for Q4 2017, down 6% quarter-over-quarter.
- 11 funds opened new BioSpecifics Technologies Corp. positions in Q4 2017 and 10 closed out, a net change of +1 holder.
- The largest BioSpecifics Technologies Corp. buyer in Q4 2017 was Stonepine Capital Management, an estimated $7.85M added.
- The largest BioSpecifics Technologies Corp. seller in Q4 2017 was Northpointe Capital, an estimated $2.47M sold.
Based on aggregated 13F filings for Q4 2017.